GPT and COVID-19: One of them had a moderate elevation of ALT (120 U/L) within a week of hospitalization, while the other showed no such abnormalities.11 In the initial cohort described from China, 2.7% exhibited hepatitis B virus infection with no mention of worsening outcomes.26 Therefore, the association of the pre-existing liver conditions with disease prognosis and outcomes in COVID-19 will have to be evaluated by comprehensive data registries which recently started enrolling patients (e.g. COVID-Hep Registry and SECURE-Cirrhosis Registry).